BioWorld Science

Oct. 25, 2005

View Archived Issues

Hydroxytyrosol protects the kidney against ciclosporin-evoked oxidative stress

Read More

ICA-17043 induces sustained improvements in patients with sickle cell anemia

Read More

Cabergoline reported more effective than L-dopa in idiopathic RLS

Read More

Quetiapine shows promise in the treatment of bipolar depression

Read More

ACT 4 safety study begins for RSD-1235

Read More

CH-1504 completes phase Ia trial, begins phase Ib

Read More

BioWa inlicenses anti-FGF8 antibody

Read More

NIH grant for Friedreich's ataxia research

Read More

Maxygen supported in preventative HIV vaccine efforts

Read More

GSK Biologicals and Aeras team up on TB vaccine development

Read More

Nektar Therapeutics completes acquisition of Aerogen

Read More

CepTor to receive milestone payment for Myodur IND filing

Read More

FDA clears phase I study of neural stem cells to treat Batten disease

Read More

IRB approval for phase I study of PRX-302 for recurrent prostate cancer

Read More

Recombinant protein with exemplary thrombolytic and antithrombotic properties

Read More

Cloretazine receives fast track designation for elderly poor-risk AML patients

Read More

Brx-019 boosts immune response in diabetic mice

Read More

Armodafinil improves wakefulness and cognition in patients with sleep disorders

Read More

Interim data shows a good safety profile for Cand5 in wet AMD patients

Read More

Sirna-027 improves visual acuity of patients with CNV secondary to AMD

Read More

Update on the long-term effects and safety of anecortave acetate in AMD

Read More

Tesmilifene-mitoxantrone combination active in refractory prostate cancer

Read More

Recent patents describe novel therapeutic agents for depression, anxiety, etc.

Read More

Novel agents for HIV infection imparted in recent patent literature

Read More

Novel anticoagulant agents thrombotic disorders revealed

Read More